Showing 1 - 10 of 608
Alzheimer Data on the effectiveness of these drugs from information beyond the short-term clinical trials (e.g. long-term clinical trials and non-trial data) are now emerging. In most cases, the results indicate that, at least for some patients, continued treatment with cholinesterase inhibitors...
Persistent link: https://www.econbiz.de/10005404597
Schizophrenia is a chronic disease that typically manifests during adolescence and early adulthood. Treatment of this disease consumes a significant proportion of the healthcare budget (billions of dollars in the US). Primary management options for schizophrenia include both pharmacologic and...
Persistent link: https://www.econbiz.de/10005404603
The prevalence of dementia, and in particular Alzheimer's disease, is expected to increase dramatically in the elderly population over the next few decades. Because of the possibilities of pharmacological and psychosocial interventions, which aim to slow down or even prevent progress of the...
Persistent link: https://www.econbiz.de/10005590130
Alzheimer's disease is a common disorder in the elderly, and a cure is not currently available. This article summarises the intervention studies that have been done in Alzheimer's disease research and discusses assessment tools and outcome measures used in these studies. Current approaches are...
Persistent link: https://www.econbiz.de/10005590201
Alzheimer disease is a common, progressive neurodegenerative disorder of the elderly, affecting approximately 3% of individuals 65-74 years of age, and up to half of those aged =85 years. Along with progressive loss of memory and cognitive function, other symptoms include depression and...
Persistent link: https://www.econbiz.de/10005448926
Clinical practice guidelines have gradually become a normal part of daily life for many clinicians. In order to provide good support for practitioners and patients in their decisions on appropriate care, the practice guidelines should be of high quality, i.e. developed by a credible...
Persistent link: https://www.econbiz.de/10005590099
Suicide is a global phenomenon. It is estimated that 0.5-1.2 million people worldwide die by suicide each year. Taking into account the global epidemiologic data concerning suicide and the economic impact of this phenomenon on diverse societies, this review aims to examine national suicide...
Persistent link: https://www.econbiz.de/10005590177
When considering the trends in disease management, the focus of healthcare in the US has shifted from communicable diseases, which can most often be managed successfully, to chronic diseases, which are currently not managed very well. Chronic diseases, such as diabetes mellitus, become a...
Persistent link: https://www.econbiz.de/10005448795
In response to an increase in the number of elderly people and increasing medical costs, the Japanese government implemented the Long-Term Care Insurance (LTCI) system for the elderly in April 2000. Three years have passed since the LTCI was initiated. The purpose of this paper is to describe...
Persistent link: https://www.econbiz.de/10005448805
The recognition that the early phase of psychosis is a critical period in the long-term trajectory of psychosis has ignited the concept of early intervention and initiated a process of service reform and the development of new protocols for the management of psychosis, examples of which are...
Persistent link: https://www.econbiz.de/10005448823